GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹13,309 Cr | ₹17,566 Cr | ₹15,397 Cr | ₹14,069 Cr | ₹13,229 Cr |
What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹13,309 Cr |
Mar2023 | ₹17,566 Cr |
Mar2022 | ₹15,397 Cr |
Mar2021 | ₹14,069 Cr |
Mar2020 | ₹13,229 Cr |
How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹13,309 Cr | -24.23 | |
Mar2023 | ₹17,566 Cr | 14.08 | |
Mar2022 | ₹15,397 Cr | 9.44 | |
Mar2021 | ₹14,069 Cr | 6.35 | |
Mar2020 | ₹13,229 Cr | - |
Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹40,842.8 Cr | 4.8% | 5.2% | 40% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.9% | 1.8% | 14% | Stock Analytics | |
DIVIS LABORATORIES | ₹166,750.0 Cr | 5.7% | 9.6% | 58.6% | Stock Analytics | |
CIPLA | ₹121,122.0 Cr | -0.8% | 1.2% | 6.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,487.0 Cr | 0.8% | 1.2% | 25.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,680.0 Cr | 2.9% | 6.5% | 4.3% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 4.8% |
5.2% |
40% |
SENSEX | 3.6% |
9.5% |
13.3% |
You may also like the below Video Courses